Congressional Testimony

DCHSB—Duke Center for HIV Structural Biology

Visual and Medical Arts at the Research Technologies Branch (RTB)

Diagnosing Food Allergy

The gold standard for diagnosing food allergy is an oral food challenge. In this procedure, a food is eaten slowly, in gradually increasing amounts, under medical supervision to accurately diagnose or rule out a true food allergy. However, physicians use oral food challenges cautiously because the procedure is time-consuming, requires highly trained personnel, and can cause an acute allergic reaction.

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Influenza Information for Researchers

NIAID is conducting and supporting research to find new and improved ways to diagnose, treat and prevent influenza infection. This includes working toward a universal flu vaccine that could provide long-lasting protection against multiple strains of influenza, such as those that cause seasonal flu as well as emerging forms capable of causing a global pandemic.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.

Highlights

This image shows three influenza A (H5N1/bird flu) virus particles (rod-shaped; orange).
Three influenza A (H5N1/bird flu) virus particles (rod-shaped; orange). Note: Layout incorporates two CDC transmission electron micrographs that have been repositioned and colorized by NIAID. Scale has been modified.
Credit
CDC and NIAID

NIAID Research Agenda for 2024 H5N1 Influenza

NIAID has mobilized its intramural and extramural-supported research infrastructure to provide scientific support to the U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS). 

""

Augmented Reality: Get the PathogenAR App

Explore interactive stories about pathogens and pathogenic disease using touch gestures or a Merge Cube Device. 

Also check out strategies NIAID researchers are using to develop a single vaccine targeting the many types of Influenza virus.

Support for Research

Funding

NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential or related funding for influenza research.

Program Officers

For contact information, search the NIH Enterprise Directory.

  • Dr. Christopher Roberts, Respiratory Pathogens Clinical Research Section Chief
  • Dr. Diane Post, Viral Respiratory Diseases Section Chief
  • Nita Basu, MSc, PhD, Program Officer, Viral Respiratory Drug Development and Diagnostic Development
  • Steven Black, MPH, Program Coordinator, Centers of Excellence for Influenza Research and Response (CEIRR)
  • Yichen Cheng, PhD, Scientific Program Coordinator, Collaborative Influenza Vaccine Innovation Centers (CIVICs)
  • Dr. Jennifer Gordon, Program Officer, Influenza and Coronavirus Vaccine Development

See more program officers in the Respiratory Diseases Branch

Search all NIAID funding opportunities and announcements

Resources for Researchers

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for influenza virus researchers.

For researchers developing products such as diagnostics, vaccines, or drug therapies, check out NIAID's support for infectious disease product developers.

Connect with Other Researchers

Search for scientists at NIAID who research influenza in the scientist directory.

Search for scientists funded by NIAID who research influenza on RePORTER.

Programs & Networks

Read more about NIAID-supported programs and networks that further influenza research

Publications and Meeting Summaries

See recent articles on influenza in PubMed.

Past meeting summaries

Follow Us on Social Media

@NIAIDNews on X
Resources for Researchers email updates
NIAID on LinkedIn
NIAID on Facebook
NIAID on Instagram

Employee Testimonial - Patricia D’Souza, Ph.D.

Dr. Patricia D’Souza is Team Leader of the Clinical Laboratory Program in the Vaccine Clinical Research Branch of the Division of AIDS, NIAID. The Branch funds the HIV Vaccine Clinical Trials Network (HVTN). This is the largest international program for testing vaccines investigates ways to prevent infection with HIV, the virus that causes AIDS.

Questions and Answers for NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity

Texas Biomed Tapped for National “Dream Team” Developing Antivirals Against COVID-19 and Other Threats

Link Type
Funded-research
Publish or Event Date
Link URL
https://www.txbiomed.org/news-press/news/avidd-antiviral-drug-discovery-centers/
Research Institution
Texas Biomedical Research Institute
Short Title
New Technology Could Dramatically Improve Texas Biomed Tapped for National “Dream Team” Developing Antivirals Against COVID-19
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

New Technology Could Dramatically Improve Response Time for Biospecimen Samples’ Processing

Link Type
Funded-research
Publish or Event Date
Link URL
https://phoenixmed.arizona.edu/newsroom/news/new-technology-could-dramatically-improve-response-time-biospecimen-samples
Research Institution
University of Arizona College of Medicine
Short Title
New Technology Could Dramatically Improve Response Time for Biospecimen Samples’ Processing
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald
Subscribe to